Bookmark

Add to MyYahoo RSS

Angioedema News

News on Angioedema continually updated from thousands of sources around the net.

Mar 14, 2014 | The Motley Fool

Why Dyax Corp. Shares Dipped

So what: According to Dyax's press release this morning, it has filed to sell 8 million shares of common stock at $9.25 per share, an 8.9% discount to yesterday's closing price.

Comment?

Related Topix: Medicine, Health

Tue Mar 04, 2014

Seeking Alpha

New Sources Of Revenue And Profitability Are In The Future For Dyax

Biotech companies are intriguing as possible investments not only for their potential stock gains, but also for their contributions to help improve and save the lives of individuals.

Comment?

Related Topix: Biotech, Medicine, Dyax, Healthcare Industry, Health, Healthcare Law, Law

Sun Feb 23, 2014

Reuters

BRIEF-Pharming and Salix say FDA extended PDUFA date for angioedema drug Ruconest

If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links.

Comment?

Related Topix: Medicine, Health

•••
•••
•••
•••
•••
•••
•••
•••
•••